The £13,000 estimate was up-rated for inflation to £15,000 per QALY as part of 2016 work to look at the cost-effectiveness threshold that should be used for decision-making for vaccination and ...

The quality-adjusted life years has shown staying power in cost-effectiveness calculations, but some say it has major flaws ...

were accepted for review (Table 1) across six PEGylated drugs (PFIL, PLD, PA 2a and 2b, PASP and PE). Our literature search identified 15 studies that evaluated the cost–effectiveness of PFIL ...

It has implicitly been assumed that should legitimate, valid and reliable equity weights become available, it would be a straightforward task to incorporate them as a separate simple calculation after ...